Abstract
The Tie-2 receptor has been shown to play a role in angiogenesis in atherosclerosis. The conventional method assaying the level of soluble Tie-2 (sTie-2) was ELISA. However, this method has some disadvantages. The aims of this research are to establish a more simple detection method, the optical protein-chip based on imaging ellipsomtry (OPC-IE) applying to Tie-2 assay. The sTie-2 biosensor surface on silicon wafer was prepared first, and then serum levels of sTie-2 in 38 patients with AMI were measured on admission (day 1), day 2, day 3 and day 7 after onset of chest pain and 41 healthy controls by ELISA and OPC-IE in parallel. Median level of sTie-2 increased significantly in the AMI patients when compared with the controls. Statistics showed there was a significant correlation in sTie-2 results between the two methods (r=0.923, P0.01). The result of this study showed that the level of sTie-2 increased in AMI, and OPC-IE assay was a fast, reliable, and convenient technique to measure sTie-2 in serum. © 2009 Informa UK Ltd.
Author supplied keywords
Cite
CITATION STYLE
Wang, C. L., Li, J. Q., Li, H. W., Jin, G., Wang, Z. H., Meng, Y. H., & Xiu, R. J. (2009). Soluble angiopoietin receptor tie-2 in patients with acute myocardial infarction and its detection by optical protein-chip. Artificial Cells, Blood Substitutes, and Biotechnology, 37(4), 183–186. https://doi.org/10.1080/10731190903043416
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.